Strides Arcolab gets US FDA nod for cancer treatment drugs
September 30th, 2011
Pharma company Strides Arcolab unit Onco Therapies has received US Food and Drugs Administration (FDA) approval for Paclitaxel injection used to treat ovarian cancer, breast cancer and non-small cell lung cancer.
Onco Therapies also received tentative approval for Oxaliplatin injection, another chemotherapy drug used to treat cancer of the colon and rectum, Strides Arcolab said Friday.